Article Research: The Impact of Coliform Bacteria Co-Cultured Secondary Metabolites on Certain Cancer Cell Lines

Mohammed S. Abbas; Esraa Jaafar Saheb; Athmar Jassim Mukhit; Ali Abbas Kadhim

doi:10.55544/sjmars.3.4.4

Authors

Mohammed S. Abbas Department of Molcular biology, Iraqi Center for Cancer and Medical Genetic Research, Mustansiriyah University, Baghdad, IRAQ.
Esraa Jaafar Saheb Department of Molcular biology, Iraqi Center for Cancer and Medical Genetic Research, Mustansiriyah University, Baghdad, IRAQ.
Athmar Jassim Mukhit Department of Molcular biology, Iraqi Center for Cancer and Medical Genetic Research, Mustansiriyah University, Baghdad, IRAQ.
Ali Abbas Kadhim High Institute for Infertility Diagnosis and ART's, Al-Nahrain University, Baghdad, IRAQ.

DOI:

https://doi.org/10.55544/sjmars.3.4.4

Keywords:

esophageal cancer, E. Coli, Klebsiella pneumoniae, secondary metabolites

Abstract

In order to avoid host defenses or maintain effective viral transmission as well as survival, viruses have developed a variety of strategies. Numerous DNA tumour viruses alter host DNA the enzymes methyl to cause epigenetic instability of hosting cells' immune-related genes regulation. Anti-tumor immune system responses were often associated with the host immunological mechanisms that were inhibited by virus-induced aberrant DNA methylation. In this instance, researchers discuss the processes including host-virus relationships that DNA tumor viruses utilize to control recipient Genome of their DNA with order to elude antimicrobial defense. This process might assist to create an immunological milieu that aids in the proliferation of malignancies. Positive outcomes are being seen in current immunotherapy investigations in treating various malignancies; yet, a considerable proportion of non-responders need the identification of new targeting for immunotherapy’s against cancer. Consequently, knowing how cancer-causing pathogens evade the immunological system could potentially reverse immunological reduction to avoid or cure related malignancies.

References

Abdelghani Z, Hourani N, Zaidan Z, Dbaibo G, Mrad M, Hage-Sleiman R. Therapeutic applications and biological activities of bacterial bioactive extracts. Arch Microbiol. 2021 Oct;203(8):4755-4776. doi: 10.1007/s00203-021-02505-1. Epub 2021 Aug 9. PMID: 34370077; PMCID: PMC8349711.

Al-Rubaye, A. F., Kadhim, M. J., & Hameed, I. H. (2017). Characterization of antifungal secondary metabolites produced by Klebsiella pneumoniae and screening of its chemical compounds using GC-MS. International Journal of Current Pharmaceutical Review and Research, 8(2), 141-148.‏

Altaee, N., Kadhim, M. J., & Hameed, I. H. (2017). Characterization of metabolites produced by E. coli and analysis of its chemical compounds using GC-MS. International Journal of Current Pharmaceutical Review and Research, 7(6), 13-19.‏

Chang CC, Chen WC, Ho TF, Wu HS, Wei YH (2011) Development of natural anti-tumor drugs by microorganisms. J Biosci Bioeng 111(5):501–511

Coleman OI, Haller D (2018) Bacterial signaling at the intestinal epithelial interface in infammation and cancer. Front Immunol 8:1927

Khalifa SAM, Elias N, Farag MA, Chen L, Saeed A, Hegazy MF, Moustafa MS, Abd El-Wahed A, Al-Mousawi SM, Musharraf SG, Chang FR, Iwasaki A, Suenaga K, Alajlani M, Göransson U, El-Seedi HR (2019) Marine natural products: a source of novel anticancer drugs. Mar Drugs 17(9):491

Lichtman SM (2013) Global initiatives to enhance cancer care in areas of limited resources: what ASCO members are doing and how you can become involved. Am Soc Clin Oncol Educ Book. https://doi.org/10.14694/EdBook_AM.2013.33.411

Mohan, C. D., Rangappa, S., Nayak, S. C., Jadimurthy, R., Wang, L., Sethi, G., ... & Rangappa, K. S. (2022, November). Bacteria as a treasure house of secondary metabolites with anticancer potential. In Seminars in cancer biology (Vol. 86, pp. 998-1013). Academic Press.‏

Ramirez-Labrada AG, Isla D, Artal A, Arias M, Rezusta A, Pardo J, Galvez EM (2020) The influence of lung microbiota on lung carcinogenesis immunity, and immunotherapy. Trends Cancer 6:86–97.

Rawa’a, A. M. (2018). Cytotoxic activity of taraxacum officinale ethanolic plant extract against human breast cancer (MCF-7) cells and human hepatic (WRL-68) cells. Iraqi Journal of Cancer and Medical Genetics, 11(1).‏

Safarpour A, Ebrahimi M, Shahzadeh Fazeli SA, Amoozegar MA (2019) Supernatant metabolites from halophilic archaea to reduce tumorigenesis in prostate cancer in-vitro and in-vivo. Iran J Pharm Res 18(1):241–253

Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590

Tan LT, Chan CK, Chan KG, Pusparajah P, Khan TM, Ser HL, Lee LH, Goh BH (2019) Streptomyces sp. MUM256: a source for apoptosis inducing and cell cycle-arresting bioactive compounds against colon cancer cells. Cancers 11(11):1742

Thomas, A. T., Rao, J. V., Subrahmanyam, V. M., Chandrashekhar, H. R., Maliyakkal, N., Kisan, T. K., ... & Udupa, N. (2011). In vitro anticancer activity of microbial isolates from diverse habitats. Brazilian Journal of Pharmaceutical Sciences, 47, 279-287.‏

Zhao, Y., Liu, Y., Li, S., Peng, Z., Liu, X., Chen, J., & Zheng, X. (2021). Role of lung and gut microbiota on lung cancer pathogenesis. Journal of Cancer Research and Clinical Oncology, 147(8), 2177-2186.‏